Publications by authors named "Inhye Ahn"

Claim this Profile
I
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.
Reid W Merryman, Justin Kline, Robert A Redd, Harrison Olszewski, Emma Welsh, Inhye E Ahn

Blood Neoplasia· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 Study.
Andy Itsara, Victoria M Rogness, Laura Samples, Constance M Yuan, Hao-Wei Wang, Inhye E Ahn

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab.
Rui Mu, Katherine M Hornick, Neelam Redekar, Jonathan Chen, Pia Nierman, Inhye E Ahn

J Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib.
Emily Tomasulo, Andy Itsara, Mark Haigney, Douglas R Rosing, Inhye E Ahn

Heart Rhythm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL.
Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, Christina Papangelou, Evangelia Minga, Inhye E Ahn

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.
Christine E Ryan, Inhye E Ahn, Aswin Sekar, Andrew Rawstron, Julia Almeida

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, Daniel S Choi, Stacey M Fernandes, Inhye E Ahn

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Inhye E Ahn

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL.
Jacob D Soumerai, Jacqueline Barrientos, Inhye Ahn, Catherine Coombs, Douglas Gladstone

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Inhye E Ahn

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells.
Sivasubramanian Baskar, Haiyong Peng, Erika M Gaglione, Elizabeth J Carstens, Margaret A Lindorfer, Inhye E Ahn

Blood· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder.
Annie Liu, Lakshmi Nayak, Waihay J Wong, Inhye E Ahn, Naoka Murakami

Kidney Int Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of apoptosis in chronic lymphocytic leukemia.
Inhye E Ahn, Matthew S Davids

Semin Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.
Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Markers in the Era of Targeted Therapies.
Sorang Kang, Inhye E Ahn

Acta Haematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Reid W Merryman, Robert A Redd, Arnold S Freedman, Inhye E Ahn, Jennifer R Brown

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A giant stem-group chaetognath.
Tae-Yoon S Park, Morten Lunde Nielsen, Luke A Parry, Martin Vinther Sørensen, Mirinae Lee, Inhye Ahn

Sci Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.
Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, Chingiz Underbayev, Pamela L Tuma, Inhye E Ahn

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting.
Maissa Mhibik, Erika M Gaglione, David Eik, John Herrick, Janet Le, Inhye E Ahn

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy.
Jennifer A Woyach, Paolo Ghia, John C Byrd, Inhye E Ahn, Carol Moreno

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts.
Deyi Zhang, Hailey M Harris, Jonathan Chen, Jen Judy, Gabriella James, Inhye E Ahn

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma.
Reid W Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Inhye E Ahn

Hemasphere· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.
Jennifer A Woyach, Paul M Barr, Thomas J Kipps, Jacqueline C Barrientos, Inhye E Ahn

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting initial therapy in CLL.
Inhye E Ahn, Jennifer R Brown

Hematology Am Soc Hematol Educ Program· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL.
Christopher Pleyer, Kerry J Laing, Mir A Ali, Christopher L McClurkan, Susan Soto, Inhye E Ahn

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis